News

Hims & Hers Health Is Looking to Cash In on This Novo Nordisk Blunder
Key Points Hims & Hers Health is entering the Canadian market.The company will offer a generic version of semaglutide in the ...
Hims & Hers hit with growing number of investor lawsuits after Novo deal exit
Hims & Hers (HIMS) stock in focus as the company faces a growing number of lawsuits following Novo Nordisk's (NVO) decision ...
Zacks Investment Research on MSN15h
Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know
Hims & Hers Health, Inc. (HIMS) ended the recent trading session at $50.46, demonstrating a -3.02% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered ...
Hims & Hers Health Plans Entry into Canada
Hims & Hers Health plans to expand into Canada, timing it with the new availability of the generic weight loss medication on the market for the first time.